Identification of CDH11 as an ASD risk gene by matched-gene co-expression analysis and mouse behavioral studies

Nan Wu,Yue Wang,Yi-Hsuan Pan,Xiao-Bing Yuan
DOI: https://doi.org/10.1101/2020.02.04.931121
2020-01-01
Abstract:Genetic variants of a large group of susceptibility genes have been associated with similar clinical manifestations of autism spectrum disorders (ASD), suggesting convergent function of these genes during brain development. Gene co-expression analysis has emerged as an important tool to identify convergent molecular pathways shared by ASD risk genes. In this study, four gene features, including gene size, mRNA length, mRNA abundance, and guanine-cytosine content, were found to profoundly affect gene co-expression. A new method termed “matched-gene co-expression analysis” (MGCA) was developed to screen for biologically meaningful gene co-expression relationships, taking into the consideration of the effect of these features on gene co-expression. With this method, significant convergence of the expression of high-confidence ASD risk genes (hcASDs) in the brain was demonstrated, and an improved efficacy in the prediction of convergent molecular pathways was achieved. This method also allowed the identification of “homophilic cell adhesion” as one of the convergent pathways of ASD-relevant genes. Analyses of and , two specific genes coding for homophilic cell adhesion molecules, revealed that , but not , was significantly co-expressed with hcASDs. In addition, -null mice, but not -null mice, were found to exhibit multiple autistic-like behavioral alterations. These results suggest that is an important ASD risk gene. Results of this study also highlight the importance of considering matched gene features in the analysis of gene co-expression.
What problem does this paper attempt to address?